InsidersTradesSigma
Follow the 삼익제약 stock price and the full insider trade history of the company, a listed equity based in South Korea. Shares are listed on the KR market, under the oversight of DART (FSS). Operating in the Health Care sector, 삼익제약 has recorded 13 insider filings. The latest transaction was filed on 6 July 2026 (Purchase). Among the most active insiders: 권영이. All data is openly available.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
13 of 13 declarations
Samik Pharmaceutical 是一家在健康和制药领域运营的公司，在 XKRX 交易所上市。它专注于药品的开发和分销。